ONWARD Medical Announces First Commercial Sales of ARC-EX System

Contributed by: GlobeNewswire

Tags

First commercial sale

More Like This

ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury

ONWARD ARC-EX® System Named One of TIME's Best Inventions of 2024

GlobeNewswire associated0

ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System

ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights

GlobeNewswire associated0

Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy

ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy

ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights

ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date